Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The fact that smooth muscle exists in almost every hollow organ and is involved in a large number of disease states has led to a vast increase in smooth muscle research, covering areas from testing response to antagonists and agonists to measuring the molecular force generated by a single actin filament. Yet, the exact mechanisms regulating contractile response of smooth muscle remain unsolved. Calcium has been a central player in mediating smooth muscle contraction through binding with calmodulin, although there is evidence showing that under special circumstances smooth muscle can contract without change in intracellular Ca2+. In addition to the major regulatory pathway of Ca(2+)-calmodulin-myosin light chain kinase, there are other thin filament linked regulatory mechanisms in which Ca(2+)-calmodulin dependent phosphorylation of
calponin
and caldesmon may be involved. Ca2+ sensitivity of smooth muscle contraction may vary under different situations and this has recently been recognized as an important regulatory mechanism. Examples are
protein kinase C
(
PKC
) dependent phosphorylation of myosin light chain kinase which results in partial inhibition of contraction, and activation of myosin light chain phosphatase. There is new evidence showing that not only does Ca2+ regulate contraction by regulating the interaction of contractile proteins in smooth muscle, but also that shortening of smooth muscle itself reduces intracellular Ca2+ concentration, via a negative feedback.
...
PMID:Calcium and smooth muscle contraction. 781 50
Calponin is an actin-associated regulatory protein in smooth muscle. We report that both endothelin-1 (ET-1) and phorbol 12, 13-dibutyrate (PDBu) caused a significant increase in phosphorylation of
calponin
during contraction of porcine coronary artery, while high levels of KCl were ineffective. This phosphorylation was predominantly catalyzed by activation of
protein kinase C
(
PKC
). In addition, the level of phosphorylation of
calponin
increased closely in association with the size of the contractile force induced by PDBu. Thus, the phosphorylation of
calponin
in vivo by
PKC
might modulate in part the contraction of smooth muscle that occurs in response to ET-1 or PDBu.
...
PMID:Phosphorylation of calponin mediated by protein kinase C in association with contraction in porcine coronary artery. 788 55
Polyclonal antibody against phosphorylated
calponin
was raised in rabbits by application of the peptide corresponding to residues 183-195 of
calponin
phosphorylated by
protein kinase C
. When
calponin
was incubated with
protein kinase C
, only free
calponin
was recognized by this antibody and
calponin
of native thin filament or that binding to F-actin did not. In experiments done using [gamma-32P] ATP, no radioactivity was detected except for free
calponin
. Calponin phosphorylation was suppressed in an actin dose-dependent manner and the phosphorylation of
calponin
was completely blocked when the actin molar ratio to
calponin
exceeded 10. These data suggest that phosphorylation of
calponin
by
protein kinase C
was apparently blocked by F-actin.
...
PMID:Phosphorylation of calponin by PKC is blocked by F-actin in vitro. 794 98
To help elucidate the physiological role of
calponin
(a thin-filament-linked regulatory protein) in smooth muscle contraction, the effects of its exogenous application were investigated on actin-activated MgAT-Pase activity in crude actomyosin from chicken gizzard, and on contraction induced by Ca(2+)-dependent and -independent means in arterial smooth muscle strips skinned by saponin or beta-escin. Calponin concentration dependently inhibited actin-activated MgATPase activity with a proportional increase in its binding to actomyosin and also attenuated Ca(2+)-induced contractions, in the presence or absence of calmodulin, in skinned arterial strips. Calponin, when phosphorylated by
protein kinase C
, reduced both its ability to bind to actomyosin and its inhibitory action on actomyosin MgATPase. The phosphorylated
calponin
also had no effect on the maximum Ca(2+)-induced contraction in skinned smooth muscle, suggesting that these actions of
calponin
are not nonspecific. Calponin attenuated the Ca(2+)-independent contraction observed in myosin light chain thio-phosphorylated strips, or on application of trypsin-treated myosin light chain kinase. However,
calponin
had no effect on maintained rigor contraction. These results suggest that in vascular smooth muscle,
calponin
may play a physiological role in the inhibition of Ca(2+)-regulated force, possibly through a direct action on active actin-myosin interactions.
...
PMID:Effects of exogenously applied calponin on Ca(2+)-regulated force in skinned smooth muscle of the rabbit mesenteric artery. 807 50
Calponin is a basic, approximately 34,000 M(r), smooth muscle-specific protein which is developmentally expressed in up to four isoforms. Calponin binds very strongly to actin in a Ca(2+)-independent manner and is localized to the thin filaments in smooth muscle, where it is present at a stoichiometry of 1 mol
calponin
/7 mol actin. The interaction of
calponin
with actin inhibits the actomyosin MgATPase (cross-bridge cycling rate) without affecting myosin phosphorylation. The
calponin
-actin interaction is blocked and
calponin
-mediated inhibition of the actomyosin MgATPase is reversed upon phosphorylation of
calponin
by either
PKC
or CaM kinase II; these properties are restored upon dephosphorylation of
calponin
by a type 2A protein phosphatase. Consistent with these in vitro findings,
calponin
is phosphorylated in intact smooth muscle in response to contractile stimuli. The increasing body of evidence, both in vitro and in vivo, strongly supports
calponin
phosphorylation-dephosphorylation as a thin filament-linked regulatory system in smooth muscle.
...
PMID:Calponin: thin filament-linked regulation of smooth muscle contraction. 813 72
Calponin isolated from chicken gizzard smooth muscle binds in vitro to actin in a Ca(2+)-independent manner and thereby inhibits the actin-activated Mg(2+)-adenosinetriphosphatase of smooth muscle myosin. This inhibition is relieved when
calponin
is phosphorylated by
protein kinase C
or Ca2+/calmodulin-dependent protein kinase II, suggesting that
calponin
is involved in thin filament-associated regulation of smooth muscle contraction. To further examine this possibility,
calponin
was isolated from toad stomach smooth muscle, characterized biochemically, and localized in intact isolated cells. Toad stomach
calponin
had the same basic biochemical properties as
calponin
from other sources. Confocal immunofluorescence microscopy revealed that
calponin
in intact smooth muscle cells was localized to long filamentous structures that were colabeled by antibodies to actin or tropomyosin. Preservation of the basic biochemical properties of
calponin
from species to species suggests that these properties are relevant for its in vivo function. Its colocalization with actin and tropomyosin indicates that
calponin
is associated with the thin filament in intact smooth muscle cells.
...
PMID:Characterization and confocal imaging of calponin in gastrointestinal smooth muscle. 823 86
Smooth muscle
calponin
bound to the biologically active fluorescent calmodulin [2-(4'-maleimidoanilino)naphthalene-6-sulfonic acid-calmodulin] (MIANS.CaM) with a Kd of 80 nM and produced a 3.4-fold fluorescence enhancement.
PKC
-phosphorylated
calponin
(1.3 mol of Pi/mol) bound to CaM with approximately 15-fold lower affinity. Calponin inhibited CaM (10 nM) activation of the Ca(2+)-/CaM-activated cyclic nucleotide phosphodiesterase (PDE) with an IC50 of 138 nM. The
calponin
-CaM interaction was Ca(2+)-dependent: half-maximal binding of
calponin
to MIANS.CaM occurred at pCa 6.6 with a Hill coefficient of 2.4. Stopped-flow fluorescence kinetic analysis demonstrated that EGTA chelation of Ca2+ from CaM disrupted the MIANS.CaM-
calponin
complex at a rate of 1 s-1. Calponin bound MIANS.CaM at a rate of (6.0 +/- 1.8) x 10(6) M-1s-1, and melittin and unlabeled brain CaM both disrupted the MIANS.CaM-
calponin
complex at a rate of 0.3 +/- 0.1 s-1. These studies suggest that
calponin
binds CaM with 80-fold lower affinity than myosin light-chain kinase and that
calponin
associates with CaM much slower than it associates with caldesmon or myosin light-chain kinase. The physiological relevance of the CaM-
calponin
interaction was evaluated by analysis of the effects of Ca(2+)-CaM on (i) the interaction of
calponin
with actin and (ii)
calponin
-mediated inhibition of actin-activated myosin MgATPase activity. Ca(2+)-CaM half-maximally inhibited
calponin
(2 microM) binding to smooth and skeletal muscle actins (9 microM) at 5.4 and 11 microM CaM, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases. 824 Nov 89
Calponin, a thin-filament-associated protein implicated in the regulation of smooth-muscle contraction, is phosphorylated in vitro by
protein kinase C
and Ca2+/calmodulin-dependent protein kinase II [Winder and Walsh (1990) J. Biol. Chem. 265, 10148-10155] and dephosphorylated by a type 2A protein phosphatase [Winder, Pato and Walsh (1992) Biochem. J. 286, 197-203]. Unphosphorylated
calponin
binds to actin and inhibits the actin-activated myosin MgATPase; these properties are lost on phosphorylation. Although both serine and threonine residues in
calponin
are phosphorylated, the major site of phosphorylation by either kinase is Ser-175. Calponin also undergoes phosphorylation when bound to actin in synthetic thin filaments, in a reconstituted actomyosin system, in washed myofibrils and in tissue extracts; this results in dissociation of
calponin
from actin. Tryptic phosphopeptide mapping indicates that the same sites are phosphorylated in the bound as in the isolated protein. Toad stomach
calponin
exists in at least three isoforms which differ in charge but exhibit the same molecular mass on SDS/PAGE. In a toad stomach extract, all three isoforms are phosphorylated by
protein kinase C
or Ca2+/calmodulin-dependent protein kinase II as shown by two-dimensional gel electrophoresis (non-equilibrium pH-gradient gel electrophoresis and SDS/PAGE). Calponin phosphorylation also occurs in intact toad stomach smooth-muscle strips metabolically labelled with 32Pi and stimulated to contract with carbachol. These results support the hypothesis that
calponin
may be regulated in vivo by phosphorylation-dephosphorylation.
...
PMID:Calponin phosphorylation in vitro and in intact muscle. 828 82
Smooth muscle myosin bound phosphatase (MBP) purified from chicken gizzard, which is a holoenzyme of type 1 delta protein phosphatase and dephosphorylated intact myosin, catalyzed the dephosphorylation of
calponin
phosphorylated by
protein kinase C
(PK-C). The Km of MBP for
calponin
was 0.6 microM and the Vmax was 350 nmol/min/mg. All of the multiple sites of phosphorylation by PK-C of
calponin
were completely dephosphorylated by MBP. Functionally,
calponin
dephosphorylated by MBP recovered its inhibitory effect on the actin-activated Mg(2+)-ATPase activity of myosin. Therefore, these results suggest that a type 1 delta protein phosphatase causes relaxation of smooth muscle by the dephosphorylation not only of myosin but also of
calponin
.
...
PMID:Calponin phosphatase from smooth muscle: a possible role of type 1 protein phosphatase in smooth muscle relaxation. 839 7
Caldesmon phosphatase was identified in chicken gizzard smooth muscle by using as substrates caldesmon phosphorylated at different sites by
protein kinase C
, Ca2+/calmodulin-dependent protein kinase II and cdc2 kinase. Most (approximately 90%) of the phosphatase activity was recovered in the cytosolic fraction. Gel filtration after (NH4)2SO4 fractionation of the cytosolic fraction revealed a single major peak of phosphatase activity which coeluted with
calponin
phosphatase [Winder, Pato and Walsh (1992) Biochem. J. 286, 197-203] and myosin LC20 phosphatase. Further purification of caldesmon phosphatase was achieved by sequential chromatography on columns of DEAE-Sephacel, omega-amino-octyl-agarose, aminopropyl-agarose and thiophosphorylated myosin LC20-Sepharose. A single peak of caldesmon phosphatase activity was detected at each step of the purification. The purified phosphatase was identified as SMP-I [Pato and Adelstein (1980) J. Biol. Chem. 255, 6535-6538] by subunit composition (three subunits, of 60, 55 and 38 kDa) and Western blotting using antibodies against the holoenzyme which recognize all three subunits and antibodies specific for the 38 kDa catalytic subunit. SMP-I is a type 2A protein phosphatase [Pato, Adelstein, Crouch, Safer, Ingebritsen and Cohen (1983) Eur. J. Biochem. 132, 283-287; Winder et al. (1992), cited above]. Consistent with the conclusion that SMP-I is the major caldesmon phosphatase of smooth muscle, purified SMP-I from turkey gizzard dephosphorylated all three phosphorylated forms of caldesmon, whereas SMP-II, -III and -IV were relatively ineffective. Kinetic analysis of dephosphorylation by chicken gizzard SMP-I of the three phosphorylated caldesmon species and
calponin
phosphorylated by
protein kinase C
indicates that
calponin
is a significantly better substrate of SMP-I than are any of the three phosphorylated forms of caldesmon. We therefore suggest that caldesmon phosphorylation in vivo can be maintained after kinase inactivation due to slow dephosphorylation by SMP-I, whereas
calponin
and myosin are rapidly dephosphorylated by SMP-I and SMP-III/SMP-IV respectively. This may have important functional consequences in terms of the contractile properties of smooth muscle.
...
PMID:Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase. 839 39
<< Previous
1
2
3
4
5
6
7
Next >>